MAGE-A3/HPV 16 Peptide Vaccines for Head and Neck Cancer
The present invention relates to Trojan antigens, and immunogenic compositions comprising the Trojan antigens. The present invention also relates to methods of generating an immune response in a subject using the Trojan antigens or immunogenic compositions. The present invention further relates to methods of treating squamous cell carcinoma of the head and neck (SCCHN) using the Trojan antigens and immunogenic compositions of the present invention.
US 20,100,183,646 [MORE INFO
STROME SCOTT E [US]; CELIS ESTEBAN [US]
Type of Offer:
« More Biotech Patents